OakChart

Nordicus Partners Corp

NORDHealthcare·Biotechnology·USA·Micro·NASD·Nov 11 • 3:59 PM ET

2.990.00 (0.00%)
2026-11-12 14:58 CET
Market cap
58.14 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-5.07 USD m
Free cash flow, TTM
-4.09 USD m
EPS diluted, TTM
-0.27
P/E
-
Compare

Price

NORD against its 20, 50 and 200-day averages
2050200
Patternshover a marker to name it
smoothed
RS 202.003.004.005.0049K98KVolumeMar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NORDclose 2.9920-day 3.8550-day 3.77200-day 3.932.99

68.5% under the 52-week high of 9.49 on 21 Jan 2025. 52-week low 1.25 on 25 Jun 2025. Last 15 sessions, 79.4% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Profile

NORD
52-week range, 41% of the way up
1.485.15

Nordicus Partners Corp. is a biotech company, which specializes in developing breakthrough therapeutics in diseases with unmet medical needs. It focuses on acquisition and development of drugs from innovative biotech companies in the Nordics. The company was founded on April 7, 1993 and is headquartered in Beverly Hills, CA.

IPOJun 12, 1996
Beta-1.23
ATR, 14d0.48
Rel volume0.00
Insider own66.79%
Inst own0.00%

Snapshot

6 groups

Valuation

Index-
Market Cap58.14M
Enterprise Value58.13M
Income-5.07M
Sales0.00M
Book/sh3.21
Cash/sh0.00
Dividend Est.-
Dividend TTM-
Dividend Ex-DateApr 24, 2020
Dividend Gr. 3/5Y- -
Payout-
Employees-
IPOJun 12, 1996

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B0.93
P/C5814.00
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio0.18
Current Ratio0.18
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.27
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y75.08% 47.92%
Sales past 3/5Y- -
EPS Y/Y TTM19.52%
Sales Y/Y TTM-100.00%
EPS Q/Q-70.20%
Sales Q/Q-
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own66.79%
Insider Trans0.15%
Inst Own0.00%
Inst Trans-
ROA-6.80%
ROE-8.06%
ROIC-8.23%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-22.44%
SMA50-20.63%
SMA200-23.86%
Trades-

Technical

Shs Outstand19.17M
Shs Float6.46M
Short Float-
Short Ratio-
Short Interest-
52W High5.15 -41.94%
52W Low1.48 102.03%
Volatility10.91% 9.81%
ATR (14)0.48
RSI (14)40.58
Beta-1.23
Rel Volume0.00
Avg Volume8.93K
Volume0

Performance

Perf Week-19.73%
Perf Month-25.25%
Perf Quarter35.91%
Perf Half Y-14.57%
Perf YTD-40.20%
Perf Year-39.29%
Perf 3Y-62.62%
Perf 5Y-73.42%
Perf 10Y42.60%
Recom-
Target Price-
Prev Close2.99
Price2.99
Change %0.00%

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
AC Nordic ApSDirectorJul 08 '26Buy2.0020,00040,0003,139,335Nov 12 06:15 AM

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual-4.77.23-5.405-5.765-0.304-14.266-0.288-0.315-0.221-0.2722
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.083-0.101-0.132-0.035-0.07-0.085-0.066-0.003-0.119
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Sales, annual2.918000000.0030.00500
Period201720182019202020212022202320242025TTM
Sales, quarterly00.0030.003000000
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Shares, annual0.0430.0430.0570.0575.6810.5681.1117.25219.12919.174
Period201720182019202020212022202320242025MRQ
Shares, quarterly4.9464.96517.19817.25217.34118.39918.82519.12919.174
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.010.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.010.010.01-0.000.000.000.000.00
Gross Profit-0.01-0.01-0.00-0.000.000.000.000.00
Selling, General and Administrative Excl. Other4.354.372.920.318.480.310.330.250.17
Research and Development1.621.611.33-----0.34
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-4.36-4.37-2.92-0.31-8.48-0.31-0.33-0.25-0.17
Interest Expense0.000.000.000.000.000.000.00-0.42
Unusual Expense0.79-0.33-0.000.000.00-0.020.000.000.00
Net Income Before Taxes-5.15-4.05-2.92-0.30-8.47-0.29-0.33-0.25-0.17
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-5.15-4.05-2.92-0.30-8.47-0.29-0.33-0.25-0.17
Net Income From Continuing Operations-5.07-4.00-2.90-0.30-8.47-0.29-0.33-0.25-0.17
Net Income-5.07-4.00-2.90-0.30-8.47-0.29-0.33-0.260.33
EPS (Recurring)-0.24-0.23-0.32-0.29-14.27-0.32-5.77-5.417.23
EPS (Basic, Before Extraordinaries)-0.27-0.22-0.32-0.29-14.27-0.30-5.76-5.417.77
EPS (Diluted)-0.27-0.22-0.32-0.29-14.27-0.30-5.76-5.417.23
EBITDA-4.35-4.37-2.91-0.31-8.48-0.31-0.33-0.25-0.17
Non-Operating Income (Expense)-0.00-0.00-0.000.010.010.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-0.140.53----0.000.02
Price To Earnings Ratio--------0.44
Price To Sales Ratio--8,744.812,855.87----0.62
Gross Margin---3.48------
Operating Margin---58,387.30-12,303.52-----
Net Margin---58,026.42-11,928.08-----
Shares Outstanding19.1719.1317.251.110.575.680.060.060.04
Market Capitalization58.1458.1481.646.694.836.930.050.300.14

Income statement, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q42024Q32024Q2
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.000.000.00--
Gross Profit-0.00-0.00-0.000.000.00-0.00--
Selling, General and Administrative Excl. Other0.821.201.121.210.830.891.270.51
Research and Development0.440.280.450.450.420.570.420.34
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-0.82-1.21-1.12-1.21-0.83-0.89-1.27-0.51
Interest Expense0.000.000.000.000.000.000.001E-06
Unusual Expense1.49-1.120.120.300.38-0.280.280.00
Net Income Before Taxes-2.31-0.08-1.25-1.51-1.21-0.61-1.55-0.51
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-2.31-0.08-1.25-1.51-1.21-0.61-1.55-0.51
Net Income From Continuing Operations-2.28-0.06-1.23-1.51-1.21-0.61-1.54-0.50
Net Income-2.28-0.06-1.23-1.51-1.21-0.61-1.54-0.50
EPS (Recurring)-0.06-0.04-0.06-0.07-0.05-0.05-0.12-0.10
EPS (Basic, Before Extraordinaries)-0.12-0.00-0.07-0.08-0.07-0.04-0.13-0.10
EPS (Diluted)-0.12-0.00-0.07-0.08-0.07-0.04-0.13-0.10
EBITDA-0.82-1.20-1.12-1.21-0.83-0.89--0.51
Non-Operating Income (Expense)0.000.00-0.004E-060.00-0.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.00-0.000.000.000.040.49-
Price To Sales Ratio---33,968.016,570.6016,389.7314,641.576,696.11
Operating Margin-------50,612.40-20,295.80
Net Margin-------61,438.52-20,031.40
Shares Outstanding19.1719.1318.8218.4017.3417.2517.204.97
Market Capitalization58.1461.3992.8384.8732.7481.64154.6928.80

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments0.020.020.050.010.250.135.540.170.12
Short Term Receivables0.000.000.000.040.000.000.060.670.57
Inventories0.000.000.000.000.000.000.000.000.30
Other Current Assets0.510.040.000.000.000.000.012.090.00
Total Current Assets0.530.060.050.050.250.135.612.930.99
Net Property, Plant & Equipment0.010.000.000.000.000.000.000.001.82
Total Investments and Advances2.251.931.750.000.000.000.000.000.00
Intangible Assets72.6768.200.010.000.000.000.000.000.00
Deferred Tax Assets-0.00----0.000.15-
Other Assets0.000.060.000.000.000.000.000.050.11
Total Assets75.4670.251.810.060.250.135.613.132.92
Short Term Debt Incl. Current Port. of LT Debt0.060.000.000.000.000.000.000.140.14
Accounts Payable1.111.060.010.000.000.000.040.810.54
Other Current Liabilities-0.000.000.020.030.060.050.072.180.57
Total Current Liabilities1.171.060.030.030.060.050.113.131.26
Long Term Debt0.000.000.000.000.000.000.000.001.99
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities10.059.32----0.000.15-
Other Liabilities0.000.000.000.000.000.000.000.000.17
Total Liabilities11.2310.380.030.030.060.050.113.283.42
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity64.2859.871.780.030.200.085.50-0.15-0.50
Total Shareholders Equity64.2859.871.780.030.200.085.50-0.15-0.50
Accumulated Minority Interest-0.040.000.000.000.000.000.000.000.00
Total Equity64.2459.871.780.030.200.085.50-0.15-0.50
Total Liabilities & Stockholders Equity75.4670.251.810.060.250.135.613.132.92
Book Value Per Share3.363.471.600.050.031.4597.21-3.40-11.70
Tangible Book Value Per Share-0.44-0.481.600.040.031.4597.21-3.40-11.70
Full-Time Employees-------1111
Price to Book Ratio0.931.393.86174.6135.540.630.05-0.34-0.09
Return on Assets-5.49-8.05-32.02-5,555.10-151.85-11.36-5.73-5.68-7.55
Return on Equity-6.45-9.41-32.97-7,610.07-207.22-11.69-9.20--
Return on Invested Capital-6.23-4.85-16.74-30,632.06-147.18-397.56-4.66--13.62
Quick Ratio0.460.051.891.914.552.7849.200.940.55
Current Ratio0.460.051.891.914.552.7849.200.940.79

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-5.15-4.05-2.92-0.30-8.47-0.29-0.33-0.25-0.17
Depreciation0.010.010.01-----0.06
Other Funds (Non Cash)1.230.120.660.008.140.000.005.700.53
Funds from Operations-3.91-3.92-2.25-0.30-0.33-0.29-0.335.450.36
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.15-0.400.960.04-0.040.010.00-0.12-0.39
Cash from Operating Activities-4.06-4.32-1.28-0.26-0.37-0.28-0.325.33-0.03
Capital Expenditures-0.03-0.02-0.000.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.150.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.020.010.000.000.000.000.002.090.09
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.00-2.150.00
Other Sources0.000.000.000.000.000.000.000.050.00
Cash from Investing Activities-0.01-0.010.150.000.000.000.00-0.020.09
Cash Dividends Paid0.000.000.00-0.000.000.000.000.000.00
Change in Capital Stock3.994.281.080.310.120.400.000.190.00
Repurchase of Common Pref Stock-0.08-0.080.000.000.000.000.000.000.00
Sale of Common Pref Stock4.074.351.080.310.120.400.000.190.00
Proceedsfrom Stock Options4.074.350.190.000.000.400.000.190.00
Issuance or Reduction of Debt, Net0.080.060.000.000.000.000.00-0.14-0.01
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.010.00-5.090.000.00
Other Financing Activities Uses0.000.000.000.000.000.00-5.090.000.00
Cash from Financing Activities4.074.341.080.310.130.40-5.090.05-0.01
Exchange Rate Effect-0.000.000.03-0.000.00----
Net Change in Cash-0.000.00-0.030.04-0.240.12-5.415.370.05
Free Cash Flow-4.09-4.34-1.28-0.26-0.37-0.28-0.325.33-0.03
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-------0.6136.47
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Cash & Short Term Investments0.010.020.190.240.010.02
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets0.290.510.450.240.150.04
Total Current Assets0.300.530.640.480.160.06
Net Property, Plant & Equipment0.010.010.010.010.000.00
Total Investments and Advances0.762.251.121.251.551.93
Intangible Assets72.0172.6774.0674.1074.3668.20
Deferred Tax Assets-----0.00
Other Assets0.020.000.020.040.050.06
Total Assets73.1075.4675.8675.8876.1270.25
Short Term Debt Incl. Current Port. of LT Debt0.080.060.000.000.000.00
Accounts Payable1.581.110.901.011.621.06
Other Current Liabilities-0.00-0.000.000.000.000.00
Total Current Liabilities1.671.170.901.011.621.06
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities9.9210.0510.2010.2110.249.32
Other Liabilities0.000.000.000.000.000.00
Total Liabilities11.5911.2311.1111.2211.8610.38
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity61.5964.2864.7764.6764.2659.87
Total Shareholders Equity61.5964.2864.7764.6764.2659.87
Accumulated Minority Interest-0.08-0.04-0.020.000.000.00
Total Equity61.5164.2464.7564.6764.2659.87
Total Liabilities & Stockholders Equity73.1075.4675.8675.8876.1270.25
Book Value Per Share3.213.363.443.513.713.47
Tangible Book Value Per Share-0.54-0.44-0.49-0.51-0.58-0.48
Price to Book Ratio0.930.941.421.280.561.39
Return on Assets-6.80-5.49-6.71-10.06-7.94-8.05
Return on Equity-8.06-6.45-7.37-11.53-9.16-9.41
Return on Invested Capital-3.70-0.09-1.89-2.34-1.88-1.01
Quick Ratio0.180.460.710.480.100.05
Current Ratio0.180.460.710.480.100.05

Cash flow, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Net Income-2.31-0.08-1.25-1.51-1.21-0.61
Depreciation0.000.000.000.000.000.00
Other Funds (Non Cash)1.49-0.820.130.440.38-0.24
Funds from Operations-0.82-0.90-1.12-1.07-0.83-0.85
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.660.22-0.34-0.690.410.46
Cash from Operating Activities-0.16-0.68-1.46-1.76-0.43-0.39
Capital Expenditures-0.010.00-0.01-0.010.000.00
Net Assets From Acquisitions0.000.000.000.000.00-0.01
Sale of Fixed Assets and Businesses0.012E-050.010.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.000.00-0.00-0.010.00-0.01
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.120.451.412.010.410.31
Repurchase of Common Pref Stock0.000.00-0.080.000.000.00
Sale of Common Pref Stock0.120.451.492.010.410.31
Proceedsfrom Stock Options0.120.451.492.010.410.00
Issuance or Reduction of Debt, Net0.020.060.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.150.511.412.010.410.31
Exchange Rate Effect0.00-0.000.00-0.000.000.07
Net Change in Cash-0.02-0.17-0.050.23-0.01-0.01
Free Cash Flow-0.17-0.67-1.47-1.77-0.43-0.39

Revenue breakdown

Services-Management Consulting Services2024: 5.00K
United States2024: 5.00K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
No short interest data.

Option chain

expiry 2026-11-12
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-124Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-298-A12BSEC
2026-10-29CERTSEC
2026-10-218-KCurrent report2026-10-21SEC
2026-10-148-KCurrent report2026-10-14SEC
2026-09-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-09-178-KCurrent report2026-09-16SEC
2026-09-048-KCurrent report2026-09-04SEC
2026-08-13NT 10-Q2026-06-30SEC
2026-07-1410-KAnnual report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-07-138-KCurrent report2026-07-13SEC
2026-06-29NT 10-K2026-03-31SEC
2026-06-238-KCurrent report2026-06-23SEC
2026-02-1310-QQuarterly report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-048-KCurrent report2026-02-04SEC
2026-01-058-KCurrent report2026-01-05SEC
2025-12-058-KCurrent report2025-12-05SEC
2025-11-1410-QQuarterly report pursuant to Section 13 or 15(d)2025-09-30SEC
2025-10-284Statement of changes in beneficial ownership of securities2024-11-15SEC
2025-10-14SCHEDULE 13DSEC
2025-10-144Statement of changes in beneficial ownership of securities2024-12-19SEC
2025-10-14SCHEDULE 13DSEC
2025-09-294Statement of changes in beneficial ownership of securities2025-02-18SEC
2025-09-29SCHEDULE 13D/ASEC
2025-09-198-KCurrent report2025-09-19SEC
2025-08-2010-QQuarterly report pursuant to Section 13 or 15(d)2025-06-30SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-0740.00K100
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
-

Funds

Fund% owned
-

OakChart. NORD. Cached 15 minutes.

Some panels did not load: ratings, news, si.